Targeting MMGT1 enhances immunotherapy efficacy in triple-negative breast cancer
Cell Reports Medicine
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Targeting MMGT1 enhances immunotherapy efficacy in triple-negative breast cancer. // Cell Reports Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S2666379126005379?dgcid=rss_sd_all
Targeting MMGT1 enhances immunotherapy efficacy in triple-negative breast cancer. Cell Reports Medicine. https://www.sciencedirect.com/science/article/pii/S2666379126005379?dgcid=rss_sd_all
“Targeting MMGT1 enhances immunotherapy efficacy in triple-negative breast cancer.” Cell Reports Medicine.
@article{article99885,
title = {Targeting MMGT1 enhances immunotherapy efficacy in triple-negative breast cancer},
journal = {Cell Reports Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S2666379126005379?dgcid=rss_sd_all}
}